Develops immune-cell therapies for cancer and sells milk-exosome skincare and hair-care products directly to corporate and retail customers; it seeks biopharmaceutical partners to commercialize its therapies.
20-F, filed Jun 18, 2026SL Science is a biomedical company specialized in developing innovative cellular and gene therapies. Established with a commitment to…View ↗
Our business model is centered on developing partnerships with biopharmaceutical companies to transform innovative technologies into…View ↗
Corporate Retail Customers Customers Total Exosome concentrate $ 2,086,707 70,890 2,157,597 Skin care products 4,091 9,190 13,281 Hair care…View ↗
Corporate and retail customers buy exosome and skin- and hair-care products directly; they pick up the goods at the company’s premises.
20-F, filed Jun 18, 2026The Group’s revenue from contracts with customers is derived from product revenue principally from the sales of products directly to its…View ↗
Corporate Retail Customers Customers Total Exosome concentrate $ 2,086,707 70,890 2,157,597 Skin care products 4,091 9,190 13,281 Hair care…View ↗
The performance obligations are considered to be met and revenue is recognized when the customer obtains control of the goods. Revenue is…View ↗
Competes with Adicet Bio, IN8bio, Cabaletta Bio, Precision BioSciences, TCR² Therapeutics, Gilead Sciences, Bristol Myers Squibb, Novartis, Amgen, Johnson & Johnson, GammaDelta Therapeutics, TC BioPharm, Dermoaroma, My Skin Chemistry UK, and Medicube
20-F, filed Jun 18, 2026Adicet Bio, Inc. (Nasdaq: ACET) — Allogeneic GDT platform; Phase I clinical trial (ADI-001);View ↗
Loading...
